225 related articles for article (PubMed ID: 12663802)
1. A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.
Wolff L; Koller R; Hu X; Anver MR
J Virol; 2003 Apr; 77(8):4965-71. PubMed ID: 12663802
[TBL] [Abstract][Full Text] [Related]
2. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
[TBL] [Abstract][Full Text] [Related]
4. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
5. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
6. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
8. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
9. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
10. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
Ott DE; Keller J; Sill K; Rein A
J Virol; 1992 Oct; 66(10):6107-16. PubMed ID: 1326661
[TBL] [Abstract][Full Text] [Related]
11. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
13. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
14. Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.
Wolff L; Koller R
J Virol; 1990 Jan; 64(1):155-60. PubMed ID: 2403439
[TBL] [Abstract][Full Text] [Related]
15. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
Brightman BK; Li QX; Trepp DJ; Fan H
J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
17. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
[TBL] [Abstract][Full Text] [Related]
18. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
Lander JK; Chesebro B; Fan H
J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
[TBL] [Abstract][Full Text] [Related]
19. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
20. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
Hwang YW; Yoo NK; Yang HM; Choi SY
Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
